Update on Peanut Allergy
JAMA Clinical Reviews
00:00
OIT Risks and When to Pause Doses
Abrams reports therapy-related anaphylaxis (~14–15%), advises holding doses during illness or uncontrolled asthma.
Play episode from 13:51
Transcript
Abrams reports therapy-related anaphylaxis (~14–15%), advises holding doses during illness or uncontrolled asthma.